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ABSTRACT 
Friedreich ataxia (FRDA) patients are homozygous for expanded GAA triplet-repeat 
alleles in the FXN gene. Primary neurodegeneration involving the dorsal root ganglia 
(DRG) results in progressive ataxia. While it is known that DRG are inherently sensitive 
to frataxin deficiency, recent observations also indicate that they show age-dependent, 
further expansion of the GAA triplet-repeat mutation. Whether somatic instability is 
progressive has not been systematically investigated in FRDA patients. Small pool PCR 
analysis of ~2300 individual molecules from tissues of an 18-week fetus, homozygous 
for expanded alleles, revealed very low levels of instability compared with adult-derived 
tissues (4.2% versus 30.6%, P<0.0001). Mutation load in blood samples from multiple 
patients and carriers increased significantly with age, ranging from 7.5% at 18-weeks 
gestation to 78.7% at 49y (R=0.91; P=0.0001). Therefore, somatic instability in FRDA 
occurs mostly after early embryonic development and progresses throughout life, 
lending further support to the role of postnatal somatic instability in disease 
pathogenesis.   
 
Keywords: Friedreich ataxia; GAA triplet-repeat; instability; progressive; embryonic 
development; somatic instability. 
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INTRODUCTION 
 Friedreich ataxia (FRDA) is characterized by slowly progressive sensory ataxia 
with onset usually before the age of 25y, typically associated with absent tendon 
reflexes, loss of position and vibration senses, dysarthria, and extensor plantar 
responses [1, 2]. These neurological manifestations result from primary degeneration of 
the dorsal root ganglia (DRG), associated with axonal degeneration in the posterior 
columns, spinocerebellar tracts, and the corticospinal tracts of the spinal cord, and large 
myelinated fibers in the peripheral nerves [3]. Although the rate of progression is 
variable, the mean age of loss of ambulation is 25y, and patients often die in their fourth 
or fifth decade. 
 FRDA is inherited as an autosomal recessive trait and the vast majority of 
patients are homozygous for expanded GAA triplet-repeat (GAA-TR) sequences (E 
alleles) in intron 1 of the FXN gene [4]. E alleles interfere with FXN gene transcription in 
a length-dependent manner [5, 6] and result in proportional deficiency of frataxin [7]. 
Most E alleles contain 600 – 1200 triplets, however, the spectrum of disease-causing 
alleles ranges from 66 to 1700 triplets. Disease severity and rate of progression 
correlate with the length of E alleles [8, 9, 10, 11, 12], and carriers of shorter alleles 
(<500 triplets) commonly show slower than average disease progression.  
 DRG neurons are especially sensitive to frataxin deficiency as was demonstrated 
by their selective loss in neuronal-specific, conditional, frataxin knockout mice [13]. 
Upon analysis of nervous system tissue from multiple autopsies of FRDA patients we 
recently found that there was a progressive accumulation of large expansions in the 
DRG [14]. This phenomenon was not seen in other tissues and may serve as a further 
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modulator of the progressive DRG-specific pathology seen in FRDA patients. 
Furthermore, in patients who are compound heterozygous for a conventional E allele 
and a borderline GAA-TR allele (44 – 66 triplets), somatic instability of the borderline 
allele was required for the development of the FRDA phenotype [15].  
 All of the above observations suggest that somatic instability of E alleles in FRDA 
is likely to be progressive. However, this has not been systematically investigated in 
patient-derived tissues. Given that DNA replication is able to induce instability of GAA-
TR sequences in simple model systems [16, 17], one would predict that the burst of 
cellular proliferation occurring in early embryonic development would be associated with 
enhanced somatic instability. Here we show that somatic instability of E alleles is 
progressive; it occurs mostly after early embryonic development and continues 
throughout life. These observations have important implications for the mechanism of 
somatic instability in FRDA, and lend further support to the role of progressive somatic 
instability in disease pathogenesis. 
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 RESULTS 
Somatic instability in FRDA mainly occurs after early embryonic development 
 E alleles are commonly detected by conventional PCR or genomic Southern blot 
analysis, which typically use 0.06 – 6 µg genomic DNA, thus simultaneously analyzing 
104 – 106 cells. These assays, commonly used for molecular diagnosis of patients, only 
estimate the repeat length of the “constitutional” or “most common” allele (E allele). 
However, using small pool PCR (SP-PCR), a sensitive assay that involves the use of 
very low levels of genomic DNA (typically 6 – 600 pg), it is possible to detect GAA 
triplet-repeats in individual FXN molecules (genes) [15, 18]. SP-PCR analysis of DNA 
from tissues of an 18-week fetus, homozygous for E alleles, revealed a remarkably low 
level of instability in all tissues tested (Fig. 1A; Table 1). Conventional PCR showed 
homozygous E alleles of the same size (620 / 620 triplets in blood), which therefore 
allowed accurate determination of the magnitude of allelic size variation. Analysis of 
2320 individual FXN molecules from multiple tissues revealed a cumulative mutation 
load of 4.2% (Table 1). Compared to a 24 year-old FRDA patient, homozygous for two 
E alleles of the same size (943 / 943 by conventional PCR analysis), fetal tissues had 
7.3-fold less instability than the corresponding adult-derived tissues (4.2% versus 
30.6%, P<0.0001; Fig. 1 B & C; Table 1). The overall mutation load is skewed in favor of 
contractions (3 to 4-fold more contractions) in both adult and fetal tissues (Table 1). 
Analysis of an additional 572 molecules from a primary fibroblast cell line derived from 
the fetus also revealed similarly low levels of instability (2.1%). Blood and cerebellum 
showed the highest mutation load. Interestingly, these tissues also revealed the highest 
frequency of large mutations (+ / - 20% of the progenitor allele length), which amounted 
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to 15% and 31% of all mutations in blood and cerebellum, respectively (examples are 
indicated by asterisks in Fig. 1A). Together, these data indicate that the relatively high 
level of somatic instability observed in adult-derived tissues develops after early 
embryonic development. 
 It is known that non-GAA interruptions within an E allele can stabilize the 
sequence in somatic cells in vivo [17]. To rule out the possibility that similar intra-allelic 
interruptions may be the reason for the stability seen in fetal tissues, we analyzed blood 
samples from the parents of the fetus to test if the inherited E alleles were capable of 
developing somatic instability. In contrast to the fetal sample, SP-PCR analysis of ~250 
FXN molecules derived from both of the heterozygous parents showed significantly 
higher mutation loads (61.5% [maternal], 49.8% [paternal] versus 7.5% [fetal]; P<0.0001 
in both cases; Fig. 2B). This difference is unlikely to be due to the length of the E alleles 
since the maternal E allele (680 triplets) was similar in size to the fetal E alleles (620 
triplets). This indicates that the fetal E alleles are indeed capable of developing somatic 
instability, but are nevertheless stable due to the younger age. 
 
Somatic instability in FRDA progresses throughout life 
 SP-PCR analysis of 6288 individual FXN molecules derived from a panel of 
blood samples from FRDA patients and heterozygous carriers with ages ranging from 2 
– 49y (Supplementary Table 1) showed mutation loads ranging from 17% - 78.7%, and 
it correlated significantly with the age of the donor (R=0.88; P=0.0007). Including the 
blood sample from the fetus, the mutation loads ranged from 7.5% - 78.7% and showed 
a highly significant correlation with age (R=0.91; P=0.0001; total 6835 individual FXN 
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molecules; Fig. 3), with donor age accounting for 83% of the variability. The donors 
were homozygous / heterozygous for constitutional E alleles of various sizes as 
determined by conventional PCR (346 – 1000 triplets; Supplementary Table 1), 
however no statistically significant allele length effect was observed (P=0.18 & P=0.39 
for the longer and shorter E alleles, respectively). These data indicate that somatic 
instability in vivo is progressive and increases throughout life. 
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DISCUSSION 
 The age-dependent increase in mutation load, and the remarkably low level of 
instability through early embryonic development, indicate that DNA replication is unlikely 
to be the only mechanism for somatic instability in FRDA patients. The age-dependent 
increase of mutation load in peripheral blood cells, despite their limited lifespan in the 
circulatory system, indicates that somatic instability develops progressively in 
hematopoietic progenitors, and not through the many cell divisions occurring from the 
progenitor cell stage through end cells in the peripheral circulation.  
 Our data contrast with the frequent observation of DNA instability in simple 
replication model systems established in E. coli [17] and S. cerevisiae [16]. However, 
they are consistent with the observation of progressive somatic instability of expanded 
(CAG·CTG)n repeats in tissues from patients with Huntington disease [19] and myotonic 
dystrophy [20, 21, 22], and in transgenic mouse models [23, 24, 25]. It is noteworthy 
that this commonality transcends obvious differences in the physical properties of the 
two repeat sequences, and their genomic locations. Despite this general similarity, 
instability of the expanded GAA-TR sequence involves mainly contractions [18], as 
opposed to mainly expansions of the (CAG·CTG)n sequence. Furthermore, somatic 
instability of the (CAG·CTG)n sequence is thought to progress in small incremental 
steps [20, 21, 22], but our data from fetal tissues show that somatic instability in FRDA 
may include large expansions and contractions. Indeed, given the overall low level of 
mutation in fetal tissues, the rather high prevalence of large mutations in blood and 
cerebellum indicate that the latter are single mutation events and are not due to multiple 
incremental mutations. It remains to be seen if mammalian mismatch repair proteins, so 
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critical for the development of somatic instability of (CAG·CTG)n repeats [26, 27, 28, 29], 
also mediate somatic instability of the GAA-TR sequence.  
 A potential weakness of our study is that, despite considerable effort, we were 
able to ascertain tissues from only one fetus homozygous for expanded GAA-TR 
alleles. However, the demonstration of instability in both parental alleles supports the 
case that the fetal alleles are inherently capable of somatic instability. Moreover, the 
lower instability of the 2 year-old individual (mutation load = 17.5%), and the statistically 
significant trend of increasing somatic instability through middle-age (49 y), support our 
conclusion that somatic instability in FRDA is mostly postnatal, and progresses 
throughout life. Another caveat of our study involved the use of multiple individuals of 
varying ages instead of studying a selected group of patients over time. However, the 
highly significant statistical correlation of mutation load with patient age, the lack of 
correlation with allele length, the similarity of mutation load in patients of similar ages 
(16y versus 17y, P=0.95; and 24y versus 29y, P=0.52), and our recent observation of 
age-dependent increase in somatic instability in a transgenic mouse model [30], all 
support the conclusion that somatic instability of expanded GAA-TR sequences at the 
FXN locus is age-dependent.      
 The age-dependent progression of somatic instability provides a conceptual 
framework for the connection between disease pathogenesis and somatic instability in 
FRDA. The observation that mutation load in blood increases throughout life, and the 
dramatic difference between multiple fetal and adult tissues suggest that it is likely a 
generalized phenomenon. This is likely to be the basis of the development of late onset 
FRDA in patients who carry one borderline allele (44 – 66 triplets) and one conventional 
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E allele (66 – 1700 triplets). Borderline alleles are thought to be too short to impede 
FXN gene transcription, but accumulation of expansions via somatic instability is 
thought to underlie the development of the FRDA phenotype [15]. Given our present 
results, we propose that progressive somatic instability of borderline alleles results in 
late onset FRDA. Moreover, the age-dependent accumulation of large expansions in 
DRG of FRDA patients [14] is further supported by our current observation of 
progressive somatic instability in human tissues.  
 In summary, the expanded GAA triplet-repeat sequence displays age-dependent 
increase of mutation load in somatic cells in vivo. Progressive somatic instability may 
contribute to disease pathogenesis in Friedreich ataxia. 
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MATERIALS AND METHODS 
Tissue samples: Samples from pediatric and adult FRDA patients and carriers was 
collected using institutionally approved protocols at OUHSC and INNN. Autopsy 
material from the 18-week fetus, homozygous for expanded GAA triplet-repeat 
sequences in the FXN gene, was obtained from the “Telethon Bank of Fetal Biological 
Samples” in the Facoltá di Medicina e Chirurgia, University of Naples “Federico II”, Italy 
(Director: Prof. Lucio Nitsch; funded by Telethon Italia). Pediatric and adult tissues were 
processed and analyzed in the Bidichandani lab in Oklahoma (USA). All fetal tissues 
were processed and analyzed in the Cocozza lab in Naples (Italy). 
 
Small pool PCR analysis: This was performed as described previously [18, 31]. 
Briefly, serial dilutions of human genomic DNA (starting in the range of 6 – 600 pg) were 
prepared in siliconized microfuge tubes. PCR was performed using primers 147F (5’-
GAAGAAACTTTGGGATTGGTTGC-3’) and 602R (5’-AGGACCATCATGGCCACACTT-
3’). PCR products were detected by Southern blotting using an end-labeled (TTC)9 
oligonucleotide probe. The calculation of the number of individual molecules per 
reaction was performed by Poisson analysis as described previously [18, 31]. For each 
genomic DNA sample, multiple reactions were performed using “small pools” of 10 – 25 
individual molecules per reaction to detect mutations. Mutation load was calculated as 
the proportion of amplified FXN molecules that differed by >5% in length from the 
constitutional (most common) allele, as determined by conventional PCR. 
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Statistical analysis: Proportions were compared using the Chi square test, and 
correlation of instability with age / allele length was calculated using Pearson’s 
coefficient of correlation.  
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FIGURE LEGENDS 
Figure 1: SP-PCR showing significantly low levels of somatic instability in fetal tissues. 
(A & B) Southern blots showing limited somatic variability in representative tissues of an 
18-week fetus (A) and a 24y adult patient (B), each of whom are homozygous for E 
alleles. Each lane contains “small pools” of 12 – 20 individual FXN molecules. 
Arrowheads indicate the position of the constitutional allele determined by conventional 
PCR. Asterisks indicate rare instances of large expansions/contractions despite the 
overall low level of somatic instability. DNA size markers are shown as dashes along 
the right margin, which indicate the relative positions of 1 kb (182 triplets), 2 kb (515 
triplets), 3 kb (849 triplets) & 4 kb (1182 triplets). (C) Cumulative average mutation load 
of all fetal versus adult (patient A-1) tissues analyzed showing a highly significant, 7.3-
fold lower level of somatic instability in fetal tissues compared with adult tissues. Error 
bars depict +/- 2SEM. 
 
Figure 2: SP-PCR showing instability of alleles inherited by the fetus in both 
heterozygous parents. (A) Representative SP-PCR results showing high levels of 
somatic instability of the E alleles in blood samples from the heterozygous carrier 
parents of the fetus (the arrowhead indicates the position of the single E allele in either 
parental blood sample as determined by conventional PCR; normal alleles are not 
shown). This indicates that both E alleles that were transmitted to the homozygous 
offspring are inherently capable of somatic instability. Each lane contains “small pools” 
of 17 – 20 individual FXN molecules. DNA size markers are shown as dashes along the 
right margin, which indicate the relative positions of 1 kb (182 triplets), 2 kb (515 
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triplets), 3 kb (849 triplets) & 4 kb (1182 triplets). (B) Bar graph of mutation load in the 
blood of fetus versus both parents (combined) showing a highly significant, 7-fold lower 
level of somatic instability in fetal tissues compared with adult tissues. The error bar 
depicts +/- 2SEM. 
 
Figure 3: Age-dependent increase of somatic instability in FRDA patients and carriers. 
Mutation load (Y-axis) is plotted against age (in years; X-axis) for blood samples derived 
from ten individuals. Their ages include 18-weeks gestation (plotted as 0y), 2y, 9y, 16y, 
17y, 24y, 29y, 36y, 43y, and 49y. Error bars indicate 95% confidence intervals.  
 
 Fetus Adult1  
Tissues Molecules Mutation load Contractions Expansions Molecules Mutation load Contractions Expansions P value2 
Blood 548 41 (7.5%) 29 (5.2%) 12 (2.1%) 1347 567 (42.1%) 524 (38.9%) 43 (3.2%) <0.0001 
Cerebrum 873 14 (1.6%) 13 (1.5%) 1 (0.1%) 1249 274 (21.9%) 215 (17.2%) 59 (4.7%) <0.0001 
Cerebellum 483 34 (7%) 25 (5.2%) 9 (1.9%) 1008 273 (27.1%) 212 (21%) 61 (6.1%) <0.0001 
Spinal Cord 156 1 (0.6%) 1 (0.6%) 0 (0%) 269 99 (36.8%) 80 (29.7%) 19 (7.1%) <0.0001 
Heart 156 6 (3.8%) 4 (2.6%) 2 (1.2%) 711 193 (27.1%) 113 (15.8%) 80 (11.3%) <0.0001 
Pancreas 104 1 (1%) 1 (1%) 0 (0%) 619 187 (30.2%) 114 (18.4%) 73 (11.8%) <0.0001 
Total 2320 97 (4.2%) 73 (3.1%) 24 (1%) 5203 1593 (30.6%) 1258 (24.2%) 335 (6.4%) <0.0001 
1Autopsy of a 24 year old FRDA patient; 2Comparison of mutation load  
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